1-(4-chlorophenyl)-N-[(1S)-1-[2-fluoro-3-(trifluoromethyl)phenyl]butyl]-5-methylpyrazole-4-carboxamide
C22H20ClF4N3O — CID 155511620
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(4-chlorophenyl)-N-[(1S)-1-[2-fluoro-3-(trifluoromethyl)phenyl]butyl]-5-methylpyrazole-4-carboxamide
1-(4-chlorophenyl)-N-[(1S)-1-[2-fluoro-3-(trifluoromethyl)phenyl]butyl]-5-methylpyrazole-4-carboxamide (PubChem CID 155511620) has the molecular formula C22H20ClF4N3O and a molecular weight of 453.87 g/mol. Its IUPAC name is 1-(4-chlorophenyl)-N-[(1S)-1-[2-fluoro-3-(trifluoromethyl)phenyl]butyl]-5-methylpyrazole-4-carboxamide.
Molecular Properties
| Compound Name | 1-(4-chlorophenyl)-N-[(1S)-1-[2-fluoro-3-(trifluoromethyl)phenyl]butyl]-5-methylpyrazole-4-carboxamide |
|---|---|
| PubChem CID | 155511620 |
| Molecular Formula | C22H20ClF4N3O |
| Molecular Weight | 453.87 g/mol |
| Exact Mass | 453.12 |
| IUPAC Name | 1-(4-chlorophenyl)-N-[(1S)-1-[2-fluoro-3-(trifluoromethyl)phenyl]butyl]-5-methylpyrazole-4-carboxamide |
| SMILES | CCC[C@H](NC(=O)c1cnn(-c2ccc(Cl)cc2)c1C)c1cccc(C(F)(F)F)c1F |
| InChI | InChI=1S/C22H20ClF4N3O/c1-3-5-19(16-6-4-7-18(20(16)24)22(25,26)27)29-21(31)17-12-28-30(13(17)2)15-10-8-14(23)9-11-15/h4,6-12,19H,3,5H2,1-2H3,(H,29,31)/t19-/m0/s1 |
| InChIKey | RNNMEBBKOGVZAZ-IBGZPJMESA-N |
| XLogP | 6.26 |
| TPSA | 46.92 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 453.87 |
| LogP ≤ 5 | 6.26 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155511620 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.